These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 15853472

  • 1. Ropinirole in the treatment of restless legs syndrome.
    Kakar RS, Kushida CA.
    Expert Rev Neurother; 2005 Jan; 5(1):35-42. PubMed ID: 15853472
    [Abstract] [Full Text] [Related]

  • 2. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [Abstract] [Full Text] [Related]

  • 3. Ropinirole treatment for restless legs syndrome.
    Bogan RK.
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L, Ritchie SY, Kirsch JM.
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [Abstract] [Full Text] [Related]

  • 5. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL, Freeman A, Ingram CD, Rye DB, Chakravorty S, Watts RL.
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [Abstract] [Full Text] [Related]

  • 6. Ropinirole in restless leg syndrome.
    Ahmed I.
    Mo Med; 2002 Mar; 99(9):500-1. PubMed ID: 12462942
    [Abstract] [Full Text] [Related]

  • 7. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC, Dahmen MM, Makos M, Lea JW, Carver LJ, Rasu RS.
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [Abstract] [Full Text] [Related]

  • 8. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome.
    Garcia-Borreguero D, Grunstein R, Sridhar G, Dreykluft T, Montagna P, Dom R, Lainey E, Moorat A, Roberts J.
    Sleep Med; 2007 Nov; 8(7-8):742-52. PubMed ID: 17512789
    [Abstract] [Full Text] [Related]

  • 9. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
    Montplaisir J, Karrasch J, Haan J, Volc D.
    Mov Disord; 2006 Oct; 21(10):1627-35. PubMed ID: 16874755
    [Abstract] [Full Text] [Related]

  • 10. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
    Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K, TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group.
    Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
    [Abstract] [Full Text] [Related]

  • 11. Ropinirole treatment for restless legs syndrome.
    Molnar MZ, Fornadi K, Shapiro CM.
    Drugs Today (Barc); 2006 Sep; 42(9):587-98. PubMed ID: 17028668
    [Abstract] [Full Text] [Related]

  • 12. [Ropinirole in the treatment of restless legs].
    Hellebek A, Kampmann JP.
    Ugeskr Laeger; 2005 Jun 06; 167(23):2541; author reply 2541-2. PubMed ID: 16008015
    [No Abstract] [Full Text] [Related]

  • 13. Ropinirole therapy for Parkinson's disease.
    Pahwa R, Lyons KE, Hauser RA.
    Expert Rev Neurother; 2004 Jul 06; 4(4):581-8. PubMed ID: 15853577
    [Abstract] [Full Text] [Related]

  • 14. Appropriate use of dopamine agonists and levodopa in restless legs syndrome in an ambulatory care setting.
    Molokwu OC.
    Ann Pharmacother; 2008 May 06; 42(5):627-32. PubMed ID: 18381842
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Restless legs syndrome.
    Bayard M, Avonda T, Wadzinski J.
    Am Fam Physician; 2008 Jul 15; 78(2):235-40. PubMed ID: 18697508
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.